The dawn of targeted therapy for primary myelofibrosis: Opportunities and challenges

Ruben A. Mesa

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)883-886
Number of pages4
JournalLeukemia Research
Volume31
Issue number7
DOIs
StatePublished - Jul 1 2007

Keywords

  • JAK2
  • Myeloproliferative disorders
  • PTK 787
  • Primary myelofibrosis
  • VEGF

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this